Vidal-Perez R, Bouzas-Mosquera A, Peteiro J, Vazquez-Rodriguez JM. ISCHEMIA trial: How to apply the results to clinical practice. World J Cardiol 2021; 13(8): 237-242 [PMID: 34589162 DOI: 10.4330/wjc.v13.i8.237]
Corresponding Author of This Article
Rafael Vidal-Perez, MD, PhD, Staff Physician, Servicio de Cardiología, Unidad de Imagen y Función Cardíaca, Complexo Hospitalario Universitario A Coruña (CHUAC) Centro de Investigación Biomédica en Red (CIBERCV)-Instituto de Salud Carlos III, As Xubias de Arriba - 84, A Coruña 15006, Spain. rafavidal@hotmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Aug 26, 2021; 13(8): 237-242 Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.237
ISCHEMIA trial: How to apply the results to clinical practice
Rafael Vidal-Perez, Alberto Bouzas-Mosquera, Jesus Peteiro, Jose Manuel Vazquez-Rodriguez
Rafael Vidal-Perez, Alberto Bouzas-Mosquera, Jesus Peteiro, Servicio de Cardiología, Unidad de Imagen y Función Cardíaca, Complexo Hospitalario Universitario A Coruña (CHUAC) Centro de Investigación Biomédica en Red (CIBERCV)-Instituto de Salud Carlos III, A Coruña 15006, Spain
Jose Manuel Vazquez-Rodriguez, Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña, A Coruña 15006, Spain
Author contributions: Vidal-Perez R contributed to conception and design of the editorial and edited and wrote the paper; Bouzas-Mosquera A, Peteiro J, and Vazquez-Rodriguez JM contributed to the critical revision and editing of the paper.
Conflict-of-interest statement: The authors declare that there are no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rafael Vidal-Perez, MD, PhD, Staff Physician, Servicio de Cardiología, Unidad de Imagen y Función Cardíaca, Complexo Hospitalario Universitario A Coruña (CHUAC) Centro de Investigación Biomédica en Red (CIBERCV)-Instituto de Salud Carlos III, As Xubias de Arriba - 84, A Coruña 15006, Spain. rafavidal@hotmail.com
Received: April 15, 2021 Peer-review started: April 15, 2021 First decision: May 13, 2021 Revised: May 27, 2021 Accepted: July 9, 2021 Article in press: July 9, 2021 Published online: August 26, 2021
Core Tip
Core Tip: During the last years two questions have been continuously asked in chronic coronary syndromes: Do revascularization procedures (coronary artery bypass grafting or percutaneous coronary intervention) really improve symptoms of angina? Do these techniques improve outcomes, i.e. do they prevent new myocardial infarction events and cardiovascular death? The results of ISCHEMIA might challenge the current diagnostic approach for stable angina patients recommended in the last European Society of Cardiology guidelines on chronic coronary disease that were based on studies published before the ISCHEMIA trial. In this editorial we propose our approach based on the ISCHEMIA study and the pretest probability for a positive test in patients with chronic coronary syndromes.
